ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

UBX UNITY Biotechnology Inc

1.50
0.02 (1.35%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 38,503
Bid Price 0.87
Ask Price 1.75
News -
Day High 1.52

Low
1.46

52 Week Range

High
3.82

Day Low 1.47
Share Name Share Symbol Market Stock Type
UNITY Biotechnology Inc UBX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.02 1.35% 1.50 23:00:05
Open Price Low Price High Price Close Price Previous Close
1.47 1.47 1.52 1.50 1.48
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
440 38,503 US$ 1.50 US$ 57,635 - 1.46 - 3.82
Last Trade Type Quantity Price Currency
16:50:29 1 US$ 1.52 USD

UNITY Biotechnology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
22.22M 14.62M - 0 -39.86M -2.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

UNITY Biotechnology News

Date Time Source News Article
2/05/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/10/202323:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
12/08/202315:39Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
12/06/202316:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
11/13/202306:00Edgar (US Regulatory)Form 8-K - Current report
11/03/202315:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/31/202315:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
9/27/202306:05Edgar (US Regulatory)Form 8-K - Current report
9/15/202315:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
9/15/202315:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
9/06/202315:05Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No UBX Message Board. Create One! See More Posts on UBX Message Board See More Message Board Posts

Historical UBX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.511.521.461.4850,555-0.01-0.66%
1 Month1.651.671.461.5357,976-0.15-9.09%
3 Months1.712.021.461.6793,202-0.21-12.28%
6 Months1.662.261.461.7794,690-0.16-9.64%
1 Year2.103.821.462.36112,761-0.60-28.57%
3 Years50.3053.001.4612.76742,589-48.80-97.02%
5 Years79.70154.401.4628.85669,883-78.20-98.12%

UNITY Biotechnology Description

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Your Recent History

Delayed Upgrade Clock